Insider · CIK 0001711184

Buell Jennifer

Reports to the SEC for 3 companies · LEXINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001711184

Forms 4 and 5

Insider transactions

47 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-05	AGENAGENUS INC · Stock OptionA Award	Director, See Remarks	AAward	+200K sh	—	—	200,000
2026-04-24	AGENAGENUS INC · Stock OptionA Award	Director, See Remarks	AAward	+300K sh	—	—	300,000
2026-04-24	AGENAGENUS INC · Stock OptionA Award	Director, See Remarks	AAward	+5,000 sh	—	—	5,000
2026-01-02	INKTMiNK Therapeutics, Inc.F Tax Payment	Chief Executive Officer	FTax Payment	−10K sh	$11.12	−$111K	57,942
2026-01-02	INKTMiNK Therapeutics, Inc.A Award	Chief Executive Officer	AAward	+31.5K sh	$11.12	+$350K	67,966
2026-01-02	INKTMiNK Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Executive Officer	AAward	+50K sh	—	—	50,000
2025-09-09	INKTMiNK Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Executive Officer	AAward	+50K sh	—	—	50,000
2025-09-09	INKTMiNK Therapeutics, Inc.F Tax Payment	Chief Executive Officer	FTax Payment	−5,351 sh	$15.36	−$82.2K	36,492
2025-09-09	INKTMiNK Therapeutics, Inc.A Award	Chief Executive Officer	AAward	+18.2K sh	$15.36	+$280K	41,913
2025-05-02	AGENAGENUS INCA Award	Director, See Remarks	AAward	+581 sh	$3.11	+$1,806.91	19,738
2025-04-18	AGENAGENUS INCA Award	Director, See Remarks	AAward	+869 sh	$2.08	+$1,807.52	19,157
2025-04-04	AGENAGENUS INCA Award	Director, See Remarks	AAward	+1,159 sh	$1.56	+$1,808.04	18,288
2025-03-21	AGENAGENUS INCA Award	Director, See Remarks	AAward	+1,123 sh	$1.61	+$1,808.03	17,129
2025-03-07	AGENAGENUS INCA Award	Director, See Remarks	AAward	+409 sh	$2.35	+$961.15	15,646
2025-02-21	AGENAGENUS INCA Award	Director, See Remarks	AAward	+545 sh	$3.32	+$1,809.4	15,237
2025-02-21	AGENAGENUS INCA Award	Director, See Remarks	AAward	+626 sh	$3.32	+$2,078.32	15,318
2025-02-07	AGENAGENUS INCA Award	Director, See Remarks	AAward	+516 sh	$3.50	+$1,806	14,692
2025-01-24	AGENAGENUS INCA Award	Director, See Remarks	AAward	+776 sh	$3.57	+$2,770.32	14,446
2025-01-24	AGENAGENUS INCF Tax Payment	Director, See Remarks	FTax Payment	−270 sh	$3.57	−$963.9	14,176
2024-11-14	AGENAGENUS INC · Stock OptionA Award	Director, See Remarks	AAward	+300K sh	—	—	300,000
2024-03-25	PTIXProtagenic Therapeutics, Inc.\new · PTIX Common stock OptionsA Award	Director	AAward	+75K sh	$1.74	+$131K	75,000
2024-01-16	INKTMiNK Therapeutics, Inc. · Stock OptionA Award	Chief Executive Officer	AAward	+500K sh	—	—	500,000
2024-01-16	INKTMiNK Therapeutics, Inc. · Stock OptionA Award	Chief Executive Officer	AAward	+661K sh	—	—	660,919
2023-10-11	INKTMiNK Therapeutics, Inc.J Other	Chief Executive Officer	JOther	−696K sh	—	—	232,165
2023-10-11	INKTMiNK Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Executive Officer	AAward	−696K sh	—	—	0
2023-10-03	INKTMiNK Therapeutics, Inc.F Tax Payment	Chief Executive Officer	FTax Payment	−65K sh	$0.94	−$61.4K	927,915
2023-10-02	INKTMiNK Therapeutics, Inc.F Tax Payment	Chief Executive Officer	FTax Payment	−58.6K sh	$1.04	−$61.2K	992,915
2023-09-29	INKTMiNK Therapeutics, Inc.F Tax Payment	Chief Executive Officer	FTax Payment	−25K sh	$1.15	−$28.8K	1,051,465
2023-09-27	INKTMiNK Therapeutics, Inc.M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+696K sh	—	—	1,076,465
2023-09-27	INKTMiNK Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	−696K sh	—	—	695,750
2023-01-09	INKTMiNK Therapeutics, Inc.A Award	Chief Executive Officer	AAward	+172K sh	$2.32	+$399K	380,715
2023-01-09	INKTMiNK Therapeutics, Inc. · Stock OptionA Award	Chief Executive Officer	AAward	+500K sh	—	—	500,000
2022-01-21	INKTMiNK Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Executive Officer	AAward	+680K sh	—	—	679,800
2021-06-30	AGENAGENUS INCA Award	Director, See Remarks	AAward	+10.6K sh	$5.49	+$58.2K	127,091
2021-06-15	AGENAGENUS INC · Stock OptionA Award	Director, See Remarks	AAward	+900K sh	—	—	900,000
2021-04-02	AGENAGENUS INCA Award	Director, See Remarks	AAward	+80.8K sh	$2.87	+$232K	116,494
2020-12-17	AGENAGENUS INC · Stock Option (Right to buy)A Award	Director, See Remarks	AAward	+900K sh	—	—	900,000
2020-07-18	PTIXProtagenic Therapeutics, Inc.\new · PTIX Common stock OptionsA Award	Director	AAward	+145K sh	$1.75	+$254K	145,000
2020-06-15	AGENAGENUS INC · Stock Option (Right to buy)A Award	Director, See Remarks	AAward	+10K sh	—	—	10,000
2019-12-24	AGENAGENUS INC · Stock Option (Right to buy)A Award	Director, See Remarks	AAward	+500K sh	—	—	500,000
2019-07-23	AGENAGENUS INC · Stock Option (Right to buy)A Award	Director, See Remarks	AAward	+84K sh	—	—	84,000
2019-06-19	AGENAGENUS INC · Stock Option (right to buy)A Award	Director, See Remarks	AAward	+300K sh	—	—	300,000
2018-11-07	AGENAGENUS INC · Stock Option (right to buy)A Award	Director, See Remarks	AAward	+130K sh	—	—	130,000
2018-06-20	AGENAGENUS INC · Common Stock, right to buyA Award	Director, See Remarks	AAward	+150K sh	$5.65	+$848K	150,000
2017-12-12	AGENAGENUS INCS Sale	Director, See Remarks	SSale	−3,511 sh	$3.46	−$12.2K	35,656
2017-10-09	AGENAGENUS INCA Award	Director, See Remarks	AAward	+10.4K sh	$3.59	+$37.4K	39,167
2017-09-03	AGENAGENUS INCA Award	Director, See Remarks	AAward	+4,375 sh	$3.72	+$16.3K	28,736

Recent filings

Accepted (ET)
Aug 74
Buell Jennifer0001193125-26-339949
SEC(opens sec.gov)
Apr 284
Buell Jennifer0001193125-26-187085
SEC(opens sec.gov)
Jan 144/A
Buell Jennifer0001193125-26-012914
SEC(opens sec.gov)
Jan 64
Buell Jennifer0001193125-26-004799
SEC(opens sec.gov)
Oct 34/A
Buell Jennifer0001193125-25-230098
SEC(opens sec.gov)
Sep 114
Buell Jennifer0001193125-25-201376
SEC(opens sec.gov)
May 64
Buell Jennifer0000950170-25-064636
SEC(opens sec.gov)
May 54
Buell Jennifer0000950170-25-063522
SEC(opens sec.gov)
Apr 104
Buell Jennifer0000950170-25-052895
SEC(opens sec.gov)
Mar 274
Buell Jennifer0000950170-25-046050
SEC(opens sec.gov)
Mar 244
Buell Jennifer0000950170-25-043817
SEC(opens sec.gov)
Mar 114
Buell Jennifer0000950170-25-037127
SEC(opens sec.gov)
Mar 54
Buell Jennifer0000950170-25-033526
SEC(opens sec.gov)
Feb 184
Buell Jennifer0000950170-25-022204
SEC(opens sec.gov)
Feb 44
Buell Jennifer0000950170-25-013409
SEC(opens sec.gov)
Jan 284
Buell Jennifer0000950170-25-010023
SEC(opens sec.gov)
Nov 184
Buell Jennifer0000950170-24-127931
SEC(opens sec.gov)

Companies

Address

C/O AGENUS INC. 3 FORBES ROAD

LEXINGTON, MA, 02421